A new anti-cancer molecule targets disease-causing proteins
ResearchPod
English - June 12, 2023 10:00 - 9 minutes - 6.36 MBScience Technology science research outreach education stem learning academic technology impact scicomm Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Persuasive crowdfunding video voiceovers
Next Episode: Quantum Speed Limits, Qubits, and Cutting-Edge Computing
Proteins are important biomolecules, fulfilling tasks in every cell of your body and with a central role in health and disease.
Dr. Harald Weinstabl and Dr. Will Farnaby lead collaboration at Boehringer Ingelheim and the University of Dundee working on PROTACs, a new class of molecules with the potential to selectively target and destroy disease-causing proteins.
Drs. Weinstabl and Farnaby's interdisciplinary research team has achieved significant tumor growth inhibition in mice, and this molecule is freely available to other researchers.
Read their original research: https://doi.org/10.1038/s41467-022-33430-6